QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Mycophenolic Acid in presence of Mycophenolate Mofetil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 60 µg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Myeloperoxidase (MPO) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 110 – 3,300 µg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
N-acetyl-ß-D-glucosaminidase(NAG) (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 6 – 360 U/L |
| Sample Volume: | 0.010 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | Colorimetric |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
N-Acetyltransferase 1, NAT1 (*10, *14A, *14B) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
N-Acetyltransferase 2, NAT2 (*5A, *6A, *7A, *7B, *14Aj, *14B) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Naloxone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20.0 – 2,000 pg/mL |
| Sample Volume: | 0.250 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Narcotic |
| Classification: | Drug Assays |
Naloxone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 500 pg/mL |
| Sample Volume: | 0.35 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic |
| Classification: | Drug Assays |
Naloxone (total) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 50,000 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic |
| Classification: | Drug Assays |
Nandrolone (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.0500 – 10.0 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Synthetic Steroid |
| Classification: | Drug Assays |
Naproxen (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 60 µg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Naproxen (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2.5 – 150 µg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Naproxen (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 200 µg/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Naproxen
Esomeprazole (Matrix: Human Plasma)
Esomeprazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 125 µg/mL 10 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Naratriptan (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 25,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Migraine |
| Classification: | Drug Assays |
Nateglinide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 100 – 15,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Nebivolol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 30,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Neopterin (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 2 – 250 nmol/L |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Neutrophil Gelatinase-Associated Lipocalin (NGAL) (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 0.156 – 10.0 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Nevirapine (NFV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 15 – 5,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Nicorandil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Nifedipine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 400 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Nimesulide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 100 – 10,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Nintedanib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 50 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | LC-MS/MS |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Nisoldipine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 3,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Nisoldipine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 75 – 20,000 pg/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
